22KIT
PharmaSens
Niia patch pumps
According to PharmaSens' own
website, "We are a privately held
Swiss company, located in Biel and
Neuchâtel. We involve users early
and constantly in our development.
Our products are designed based
on users' preferences, wishes, and
needs. We have an expert team
experienced in developing and
bringing products to market for
people living with diabetes. We
have strong collaborations and
valuable partnerships with the
medical device/pump development
and manufacturing community.
We hold several granted patents,
have pending applications and
guaranteed freedom to operate for
our technologies.
"We are developing a
revolutionary glucose sensor, the
smallest sensor in the world, the
size of a human hair. People living
with diabetes will no longer need to
purchase, understand, manage and
wear two devices. The niia signature
pump will be the first combined
insulin patch pump and continuous
glucose monitoring system in
one device.
Pump users have different
lifestyles and preferences.
PharmaSens is therefore developing
a portfolio of three insulin patch
pumps to meet the wide variety of
user needs.
All the products are based on the
same matchless technology. From the
first niia essential pump, to the third
niia signature pump, the world's first
pump with an integrated continuous
glucose sensor."
So, there are three insulin patch
pumps planned but built on one
technology foundation. In addition,
the company is also investing in
bringing to market the world's
smallest sensor (pictured above left).
www.pharmasens.com
PKvitality
K'Watch Glucose CGM
At ATTD 2022, PKvitality disclosed
the first-in-human results of K'Watch
Glucose, the world's first continuous
glucose monitoring (CGM)
smartwatch. Glucose monitoring is
challenging for people with diabetes
who need to do blood tests. There
can be issues regarding precision,
tolerance, and pain. Based on these
criteria, a trial was conducted at
AMCR Institute in the US.
K'Watch Glucose (pictured above)
is a smartwatch that will allow to
measure glucose continuously,
without taking blood, without
pain, by 'tasting' the skin, analyzing
interstitial fluid (ISF) through
micropoints. It displays results on
its screen and notifies users in real
time of hyper and hypoglycaemia
by alerting the wearer via
microvibrations of the smartwatch
and/or customized automated alerts.
In case of severe episodes, it also
alerts trusted people.
PKvitality is a French company
specializing in bio-wearable health
and sports solutions. The K'Watch
Glucose system enables a painless
and non-stigmatizing experience